These findings suggest that the NBF2 formula, which activates PPAR-α/γ mRNA and Sirt2-mRNA, may reverse dyslipidemia and hyperglycemia in T2DM. The gene discussed is SIRT2; the disease is type 2 diabetes mellitus.